C
ardiac surgical procedures are among the most common and expensive inpatient operations in the United States, with wide variation spending over an entire episode of care across hospitals. [1] [2] [3] [4] Recent policy efforts, including the Bundled Payments for Care Improvement-Advanced (BPCI Advanced) program, have targeted expensive episodes of care by reimbursing providers a single payment-commonly referred to as a bundled payment-for the services rendered and clinical outcomes across the entire 90-day episode. Within cardiac surgery, both coronary artery bypass grafting (CABG) and valve surgery are eligible inpatient episodes in which hospitals can participate in BPCI Advanced. 5 A frequent source of excessive costs, morbidity, and mortality among cardiac surgical patients is healthcare-associated infections (HAIs), which occur within 3% to 8% of CABG surgery patients. [6] [7] [8] Preventing postoperative pneumonia (hereafter simply pneumonia), the most common HAI among cardiac surgical patients, may help providers reduce spending and improve outcomes over a 90-day episode. 9, 10 However, the impact of pneumonia on 90-day episode payments and outcomes after cardiac surgery is not well understood. Studies have demonstrated that 30-day episode payments were substantially higher for patients experiencing postoperative complications, including HAIs. 11, 12 Outcomes, such as length of stay, operative mortality, and 30-day readmissions, were often worse among cardiac surgical patients with HAIs. 8, 9, 13 However, these studies do not examine specific complications are limited to the inpatient or 30-day episode window and focus on total episode payments, which lack detail on the specific aspects of care delivery that are driving increased spending. Moreover, few studies have explored the relationship between HAIs and episode payments and outcomes within patients undergoing valve surgery, which often occurs within the same delivery setting as CABG, and is becoming more common and expensive. 3, 14, 15 Understanding the impact of pneumonia on 90-day episode payments and outcomes might inform opportunities to succeed in a bundled payment framework.
Within this context, the objectives of the study were threefold. The first objective was to estimate the association between pneumonia and 90-day episode payments after CABG and valve surgery among Medicare beneficiaries. The second objective was to estimate the association between pneumonia and outcomes measures used by BPCI Advanced to benchmark quality of care a patient received during the 90-day episode, such as length of stay, mortality, and readmissions. The third objective was to compare average episode payments and outcomes across increasing terciles of hospital-level pneumonia rates.
METHODS
This study was reviewed by the University of Michigan Institutional Review Board and deemed to be exempt from institutional review board approval. The authors (M.P. Thompson and D.S. Likosky) had full access to all of the data in the study and take full responsibility for its integrity and the data analysis. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results. 
Data Sources and Sample

WHAT IS KNOWN
• Postoperative pneumonia is the most common healthcare-associated infection after cardiac surgery.
• Recent bundled payment efforts incentivize hospitals to reduce excessive spending in coronary artery bypass grafting and heart valve surgery episodes of care, such as spending associated with preventable infections.
WHAT THE STUDY ADDS
• Medicare beneficiaries with postoperative pneumonia had a 25% higher 90-day episode payment for coronary artery bypass grafting and heart valve surgery, which was largely attributed to more expensive index hospitalizations.
• Pneumonia was also associated with longer hospital length of stay, more frequent discharge to postacute care, worse postoperative mortality, and higher rates of 90-day all-cause readmission.
• On average, hospitals with higher rates of pneumonia had significantly higher 90-day episode payments and worse outcomes.
Postoperative Pneumonia
Within both surgical cohorts, we identified patient-level pneumonia using a previously published ICD-9 diagnostic code-based algorithm (Table I in the Data Supplement). 16, 17 We categorized patients as having pneumonia if they had any of the ICD-9 diagnosis codes after the date of the surgery (not present-on-admission, but before discharge); otherwise, beneficiaries were categorized as not having pneumonia.
Ninety-Day Episode Payments
Our primary outcome was price-standardized Medicare payments occurring during the 90-day episode of care. Price standardization ensures that variation in payments reflects differences in healthcare utilization, and not differences in geographic reimbursement. Furthermore, this process eliminates other anomalies in Medicare payment data, such as zero dollar payments. Details on the methods used to generate overall and component price-standardize Medicare payments have been previously published. 1, 2, 4, 18 Overall episode payments represent the sum of the payments for the index hospitalization, postdischarge physician services, postdischarge facility and equipment use, and hospital readmissions. We assigned physician services during the index hospitalization and postdischarge window into 4 categories using Berenson-Eggers Type of Service codes: evaluation and management, procedure, imaging and testing, and other services. Winsorization of the top and bottom 1% of overall price-standardized episode payments for each procedure cohort (CABG: n=1134; valve: n=1127) was also performed to limit the impact of extreme values on estimated averages.
Episode of Care Outcome Measures
The secondary outcomes in this study were outcome measures used by the BPCI Advanced program, including postoperative length of stay (in days), 30-day postoperative mortality, and 90-day all-cause hospital readmission. We also examined the use of postacute facility care after discharge, including the use of inpatient rehabilitation facilities, SNF, and long-term acute care. For analyses on length of stay, postacute facility use, and 90-day readmissions, we excluded patients who died during the index hospitalization (CABG: n=1215, 1.1%; valve: n=2039, 1.8%).
Statistical Analyses
We compared individual beneficiary factors by pneumonia status (absent versus present) within each surgical cohort (CABG and valve surgery) and tested for significant differences using χ 2 tests and ANOVA for categorical and continuous variables, respectively. These factors included age, sex (male versus female), race/ethnicity (non-white versus white), elective (defined as nonemergent surgery occurring on the day of admission) versus nonelective surgery, admission from home versus not from home, preoperative length of stay (in days), and Elixhauser comorbidities identified during the index hospitalization. 19 Next, we estimated risk-adjusted overall and component 90-day episode payments for each patient using hierarchical linear regression models. To obtain these estimates, we generated the model-based expected payment for each patient, adjusting for beneficiary factors. We then divided the observed payment by the expected payment and multiplied by the sample average. We then estimated the average overall and component payment by pneumonia status and the absolute and relative differences between beneficiaries with and without pneumonia. We tested for significant differences in risk-adjusted payments by pneumonia status using model t tests. We also estimated how much of the difference in overall episode payments between beneficiaries with and without pneumonia were attributed to each component category. As a sensitivity analysis, we used a generalized linear model with a log-link function to fit our data, rather than a linear model.
Finally, we compared outcomes between beneficiaries with and without pneumonia for each surgical cohort. For postoperative length of stay, we estimated the mean and SD for beneficiaries with and without pneumonia. We then used hierarchical linear regression models to estimate the adjusted difference between groups, accounting for beneficiary factors and hospital random effect. For binary outcome measures (ie, discharge to postacute care, mortality, readmission), we compared outcome rates by pneumonia status and then used hierarchical logistic regression models to estimate the adjusted odds ratio and 95% confidence intervals for the outcome by pneumonia status, adjusted for beneficiary factors and hospital random effects.
Variation in Payments and Outcomes
We eliminated episodes in very-low-volume hospitals, defined as having ≤10 episodes (CABG: n=782 episodes, 123 hospitals; valve n=1661 episodes, 325 hospitals). We then rankordered hospitals from lowest to highest pneumonia rate and separated hospitals into near equal-sized terciles by hospital observed pneumonia rates. Within each tercile, we estimated the observed and risk-adjusted pneumonia rates for all beneficiaries. Risk-adjusted rates were estimated as the ratio of observed to expected number of pneumonia cases (adjusting for beneficiary factors) from hierarchical logistic regression models, multiplied by the overall sample pneumonia rate. Using similar methodologies, we estimated risk-adjusted overall and major component episode payments and outcomes measures across tercile of hospital pneumonia rates. We tested for significant differences in episode payments and outcome measures across pneumonia rate terciles using hierarchical regression model type 3 tests for fixed effects. Last, we estimated the Pearson correlation coefficient (r) between the hospital-level risk-adjusted pneumonia rates for CABG and valve surgery.
RESULTS
In our samples of 56 728 beneficiaries undergoing CABG and 56 377 beneficiaries undergoing valve surgery, 3607 (6.4%) and 3706 (6.6%) developed pneumonia after surgery, respectively. The distribution of patient factors by pneumonia status in the CABG and valve cohorts can be found in Table 1 .
The mean (SD) risk-adjusted 90-day episode payments for CABG episodes were $38 069 ($13 378), with interquartile range of $28 330 to 40 989. The mean (SD) risk-adjusted 90-day payments for valve surgery episodes were $49 384 ($17 780), with interquartile range of $36 304 to $52 678. The distribution of risk-adjusted 90-day episode payments by surgical cohort and pneumonia status can be found in Figure 1 .
Overall, pneumonia was associated with 24.6% and 26.5% higher episode payments for Medicare beneficiaries undergoing CABG ($46 723 versus $37 496; P<0.001) and valve surgery ($61 544 versus $48 549; P<0.001), respectively (Tables 2 and 3) . Overall, 85.9% and 84.5% of the payments associated with pneumonia can be attributed to the index hospitalization in CABG and valve cohorts, respectively. In the CABG cohort, the largest absolute and relative increases in payments associated with pneumonia were in more expensive discharge DRG codes, more frequent outlier payments, increased physician evaluation, and management services during both the index hospitalization and postdischarge, increased SNF use, and more frequent readmissions. Patterns of payment increases associated with pneumonia were similar in the valve cohort. On the other hand, outpatient facility use declined in patients with pneumonia for both CABG (−$204, −17.1%) and valve cohorts (−$246, −19.7%). Estimates from the generalized linear models with a log-link function were consistent with our main results.
Outcomes were also worse among beneficiaries with pneumonia in both surgical cohorts (Table 4) . Postoperative length of stay was 4 to 5 days longer in beneficiaries with pneumonia compared with those without pneumonia. Beneficiaries were twice as likely to be discharged to a postacute care facility if they had pneumonia. The odds of 30-day postoperative mortality increased by 2.5-fold for both CABG and valve procedures. The odds of all-cause readmission increased on a relative scale by 20% and 25% for CABG and valve procedures, respectively. The average risk-adjusted pneumonia rates for beneficiaries treated in low, medium, and high pneumonia rate hospitals was 1.8%, 5.7%, and 17.1% for CABG admissions and 1.2%, 2.9%, and 13.2% for valve admissions (Table 5 ). We found a significant association between hospital pneumonia rate tercile and overall and component episode payments, with higher average payments in higher pneumonia rate terciles for Adjusted pneumonia rates and episode payments are adjusted for patient age, sex, race/ethnicity, elective surgery, admission from home, preoperative length of stay, Elixhauser comorbidities, and hospital random effect. CABG indicates coronary artery bypass grafting; DME, durable medical equipment; DRG, diagnosis-related group; and SNF, skilled nursing facility.
both CABG and valve episodes. Similarly, we found that higher hospital pneumonia rate tercile was associated with significantly worse outcomes in all measures in CABG and valve episodes, except for 90-day readmissions among CABG episodes (P=0.168). We found a moderately strong, direct correlation between riskadjusted pneumonia rates for CABG and valve surgery within hospitals (r=0.68, P<0.001; Figure 2 ).
DISCUSSION
The overall objective of this study was to examine the relationship between postoperative pneumonia and 90-day episode payments and outcomes among Medicare beneficiaries undergoing cardiac surgery. We found that pneumonia was associated with a 25% higher 90-day episode payments in beneficiaries undergoing CABG and valve surgeries, which were largely attributed to more expensive discharge diagnoses, outlier payments for extended hospital stays, additional evaluation and management physician services, increased use of SNF, and more frequent hospital readmissions. Outcomes were also inferior among beneficiaries with pneumonia, including longer length of stay, more frequent discharge to postacute care, and higher rates of mortality and readmission. We also found that pneumonia rates varied widely across hospitals, with high pneumonia rate hospitals incurring higher episode payments and worse outcomes, compared with low pneumonia rate hospitals.
Our findings are consistent with prior reports documenting postoperative HAIs as significant contributors to excess healthcare spending. 11, 12, 20 The added payments related to HAIs are primarily because of the extended hospitals stays and physician services attributed to treating and managing the complication over and above the primary reason for the hospital admission, that is, cardiac surgery. Infections also add complexity to the management and recovery of surgical patients, which may contribute to poor short-term outcomes and rehospitalization. However, to our knowledge, few reports have documented the independent impact of HAIs on payments and outcomes across the 90-day window. We provide empirical evidence that pneumonia, the most common HAI in cardiac surgery, adds substantially to episode payments to payers and increases Adjusted pneumonia rates and episode payments are adjusted for patient age, sex, race/ethnicity, elective surgery, admission from home, preoperative length of stay, Elixhauser comorbidities, and hospital random effect. DME indicates durable medical equipment; DRG, diagnosis-related group; and SNF, skilled nursing facility. the likelihood of poor outcomes for patients across the 90-day episode.
Our data also suggest that preventing HAIs, such as pneumonia, could be an effective way for hospitals to succeed under Medicare value-based payment programs, including BPCI Advanced and the Hospital Readmissions Reduction Program. Success in bundled payments depends on a hospital's ability to keep its average episode under a predetermined benchmark set by Medicare. Our data demonstrated that hospitals with lower rates of pneumonia had lower 90-day episode payments, which were largely attributed to lower spending for the index hospitalization. Moreover, we found that low pneumonia rate hospitals had fewer readmissions and subsequent spending. Future work should examine whether hospitals with fewer HAIs perform better in Medicare value-based payment programs and whether HAI prevention efforts translate to improved performance in these programs.
Preventing pneumonia after cardiac surgery may be an attainable goal. Several preoperative factors have been identified as risk factors for pneumonia, including comorbid conditions and pulmonary and cardiac function. 21 Intervening on these risk factors before surgery (eg, prehabilitation) could mitigate some of the risk of incident pneumonia. However, recent evidence suggests that patient risk factors explain only 2% to 5% of the variation in pneumonia rates between hospitals. 22 These findings suggest that hospital variation in pneumonia rates may be the product of differences in clinical care delivery between hospitals, such as ventilator and infection prophylaxis practices. Our study found that the effect of pneumonia on episode payments and outcomes was similar between procedures and that hospital-level pneumonia rates for CABG and †Excludes beneficiaries who died in hospital. valve surgery were moderately correlated. Together, these findings support the hypothesis that pneumonia rates may be independent of both patient risk factors and procedure type. Instead, variation in pneumonia rates across hospitals may be the result of differences in the delivery of care across hospitals, including clinical processes of care and structural characteristics. 23 Identifying the underlying practices and structural factors that contribute to the development of pneumonia would be critical to informing subsequent quality improvement efforts. Our study also sheds new light on postdischarge healthcare utilization in cardiac surgical patients attributed to the development of an HAI. The use of postacute care facilities after surgical admissions varies widely across hospitals nationwide. 24 High-spending hospitals for CABG surgery have been shown to use significantly more postacute care services compared with low-spending hospitals. 4 We found that Medicare beneficiaries with pneumonia were twice as likely to be discharged to a postacute care facility, including SNFs and long-term acute care facilities. Moreover, we found that high pneumonia rate hospitals have significantly higher frequency of postacute care facility use. Our findings suggest that HAIs may contribute to the variation in utilization and subsequent payments for postacute care facilities. In addition to the added costs associated with using these facilities, it can have profoundly negative health effects for patients. 25 The use of postacute care facilities may also explain why payments for outpatient facilities were significantly lower among patients with pneumonia, as the care typically received in outpatient facilities could have been shifted toward postacute care facilities. Beneficiaries with pneumonia were also found to be 20% to 25% more likely to be readmitted to the hospital within 90 days of discharge, which had only previously been demonstrated at 30 days after discharge. 8 In all, avoiding the use of postacute care facilities and hospital readmission after cardiac surgery would likely benefit patients, providers, and payers.
Our study has limitations that should be considered. First, our sample was derived using MS-DRG codes, rather than objective clinical criteria. However, the use of MS-DRG codes is policy relevant as Medicare uses them to identify eligible episodes in the BPCI Advanced program. We excluded episodes if they did not have ICD-9 procedure codes for CABG and valve surgery to eliminate unrelated or potentially miscoded episodes. Second, we relied on a claims-based algorithm to identify pneumonia, rather than clinically confirmed cases of pneumonia. We acknowledge that this method may produce false positives, although this would likely inflate our estimates of pneumonia rates and bias our findings toward the null. 16 Thus, our findings may reflect a conservative estimate on the association between pneumonia and 90-day episode payments and outcomes. Third, we recognize that the outcome measures we used in this study represent a narrow view of quality in cardiac surgery. We chose to focus on these measures because they are incorporated as quality metrics in the BPCI Advanced program. Future research should explore how pneumonia is associated with a broader set of clinical outcome measures. Fourth, we were unable to capture detailed clinical data for robust risk adjustment. However, evidence suggests that although detailed clinical data are important for patient-level prediction models, they do not explain variation in pneumonia rates across hospitals. 21, 22 
CONCLUSIONS
In this large, retrospective cohort study of Medicare beneficiaries undergoing cardiac surgery, postoperative pneumonia was associated with significantly higher payments and worse outcomes during a 90-day episode. Hospital-level pneumonia rates vary widely across hospitals, with high pneumonia rate hospitals exhibiting higher spending and inferior outcomes. Targeting HAIs, like pneumonia, may not only improve outcomes in patients but also help hospitals achieve savings under a bundled payment program.
